Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Brenda Gibbens-Bandala"'
Autor:
Pedro Cruz-Nova, Brenda Gibbens-Bandala, Alejandra Ancira-Cortez, Gerardo Ramírez-Nava, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Blanca Ocampo-García
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionMore than 1.9 million new cases of colorectal cancer and 935,000 deaths were estimated to have occurred worldwide in 2020. Therapies for metastatic colorectal cancer include cytotoxic chemotherapy and targeted therapies in multiple lines
Externí odkaz:
https://doaj.org/article/40823603a990461e9856085094bdbe1f
Autor:
Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, Brenda Gibbens-Bandala, Irma Soldevilla-Gallardo, Nancy Lara-Almazán, Melissa Rojas-Pérez, Blanca Ocampo-García, Erika Azorín-Vega, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1988 (2023)
177Lu-iPSMA is a novel radioligand developed at ININ-Mexico with a high affinity for the PSMA protein heavily expressed in cancer cells of approximately 95% of patients with metastatic castration-resistant prostate cancer (mCRPC). 177Lu-DOTATOC is a
Externí odkaz:
https://doaj.org/article/5d0dae5e07b64950ba7b769e4bd92c95
Autor:
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-García, Clara Santos-Cuevas, Enrique Morales-Avila, Guillermina Ferro-Flores
Publikováno v:
Nanomaterials, Vol 12, Iss 23, p 4181 (2022)
The fibroblast activation protein (FAP) is heavily expressed in fibroblasts associated with the tumor microenvironment, while the prostate-specific membrane antigen (PSMA) is expressed in the neovasculature of malignant angiogenic processes. Previous
Externí odkaz:
https://doaj.org/article/a45ed9b713f1416fb1cfeaa2c76bf181
Autor:
Luis Coria-Domínguez, Paola Vallejo-Armenta, Myrna Luna-Gutiérrez, Blanca Ocampo-García, Brenda Gibbens-Bandala, Francisco García-Pérez, Gerardo Ramírez-Nava, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 590 (2022)
Tumor microenvironment fibroblasts overexpress the fibroblast activation protein (FAP). We recently reported the preclinical evaluation of [99mTc]Tc-iFAP as a new SPECT radioligand capable of detecting FAP. This research aimed to evaluate the kinetic
Externí odkaz:
https://doaj.org/article/ea81d4c1c2ba436a9e74773c7fb4da5c
Autor:
Pedro Cruz-Nova, Alejandra Ancira-Cortez, Guillermina Ferro-Flores, Blanca Ocampo-García, Brenda Gibbens-Bandala
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1095 (2022)
Nanoparticles are excellent platforms for several biomedical applications, including cancer treatment. They can incorporate different molecules to produce combinations of chemotherapeutic agents, radionuclides, and targeting molecules to improve the
Externí odkaz:
https://doaj.org/article/ca9e9d9564714653857d395e9629df59
Autor:
Brenda Gibbens-Bandala, Enrique Morales-Avila, Guillermina Ferro-Flores, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Gerardo Ramírez-Nava, Blanca Ocampo-García
Publikováno v:
Polymers, Vol 11, Iss 10, p 1572 (2019)
The peptide-receptor radionuclide therapy (PRRT) is a successful approach for selectively delivering radiation within tumor sites through specific recognition of radiolabeled peptides by overexpressed receptors on cancer cell surfaces. The efficacy o
Externí odkaz:
https://doaj.org/article/72040da3ec0c4e50bcb9c85274da9ca0
Autor:
Tania, Hernández-Jiménez, Pedro, Cruz-Nova, Alejandra, Ancira-Cortez, Brenda, Gibbens-Bandala, Nancy, Lara-Almazán, Blanca, Ocampo-García, Clara, Santos-Cuevas, Enrique, Morales-Avila, Guillermina, Ferro-Flores
Publikováno v:
Nanomaterials (Basel, Switzerland). 12(23)
The fibroblast activation protein (FAP) is heavily expressed in fibroblasts associated with the tumor microenvironment, while the prostate-specific membrane antigen (PSMA) is expressed in the neovasculature of malignant angiogenic processes. Previous
Autor:
Brenda Gibbens-Bandala, Maydelid Trujillo-Nolasco, Pedro Cruz-Nova, Liliana Aranda-Lara, Blanca Ocampo-García
Publikováno v:
Nanotechnology in the Life Sciences ISBN: 9783031126574
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc93fef0e83f719653f691c77ff7fa08
https://doi.org/10.1007/978-3-031-12658-1_13
https://doi.org/10.1007/978-3-031-12658-1_13
Autor:
Maydelid, Trujillo-Nolasco, Pedro, Cruz-Nova, Guillermina, Ferro-Flores, Brenda, Gibbens-Bandala, Enrique, Morales-Avila, Liliana, Aranda-Lara, Miguel, Vargas, Blanca, Ocampo-García
Publikováno v:
Journal of biomedical nanotechnology. 17(2)
Pancreatic cancer is highly lethal and has a poor prognosis. The most common alteration during the formation of pancreatic tumors is the activation of KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) oncogene. As a new therapeutic strategy, the C1
Autor:
Clara Santos-Cuevas, Enrique Morales-Avila, Myrna Luna-Gutiérrez, Blanca Ocampo-García, Gerardo J. Ramírez-Nava, G. Ferro-Flores, Brenda Gibbens-Bandala
Publikováno v:
Polymers
Volume 11
Issue 10
Polymers, Vol 11, Iss 10, p 1572 (2019)
Volume 11
Issue 10
Polymers, Vol 11, Iss 10, p 1572 (2019)
The peptide-receptor radionuclide therapy (PRRT) is a successful approach for selectively delivering radiation within tumor sites through specific recognition of radiolabeled peptides by overexpressed receptors on cancer cell surfaces. The efficacy o